The Net Margin of Suzhou Zelgen Biopharmaceuticals Co Ltd (688266.SS) is -25.86%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -25.86% |
| 2023-12-31 | -72.09% |
| 2022-12-31 | -151.28% |
| 2021-12-31 | -236.92% |
| 2020-12-31 | -1154.12% |
| 2019-12-31 | -33594.66% |
| 2018-12-31 | -64135.00% |